查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604563

骨化二醇补充品市场：未来预测（2025-2030）

Calcifediol Supplements Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 123 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

骨化二醇补充品市场预计将以 9.21% 的复合年增长率成长，市场规模从 2025 年的 14.094 亿美元增至 2030 年的 21.893 亿美元。

骨化二醇是血液中维生素 D 的活性形式，也称为 25-羟基维生素 D3。从阳光或食物中摄取的维生素 D3 在肝臟中被羟基化并产生。用于测量体内维生素 D 水平。

骨化二醇补充品是一种更先进、更强大的维生素 D补充品。临床证明，与其他方法相比，提高维生素 D 水平的速度和效率提高 3 倍。骨化二醇一水化合物（25-羟基维生素 D3）是一种维生素 D3 类似物，透过使用胆钙化醇 25-羟化酶将维生素 D3（胆钙化醇）羟基化而获得。

全球维生素 D 缺乏症日益严重和人口老化正在推动维生素 D补充品市场的成长。骨化二醇比其他维生素 D补充品吸收得更快，可使体内维生素 D 水平增加三倍，从而导致需求增加。此外，其在治疗次发性副甲状腺机能亢进、低血钙和预防骨质疏鬆症的应用将导致骨化二醇补充品市场的成长。

骨化二醇补充品市场的驱动因素

  • 维生素 D 缺乏症的加剧推动骨化二醇补充品市场成长

全球维生素 D 缺乏症患者的数量正在增加。与此同时，全球老年人口也不断增加。这些因素创造了对维生素 D补充品的需求。骨化二醇是比其他维生素 D补充品更好的替代品。它为维生素 D 缺乏症提供了有效的解决方案，并且比传统维生素 D3补充品更快、更有效地提高维生素 D 水平。

美国国家生物技术资讯中心的一项研究，维生素 D 缺乏症的盛行率很高，76.6% 的参与者血清 25-羟基维生素 D 缺乏症低于 75 nmol/l。全球整体约 30-45% 的人（即约 10 亿人）缺乏维生素 D。

骨化二醇补充品市场的地理前景

  • 预测期内，北美将成为骨化二醇补充品的最大市场

从地区来看，全球市场分为亚太地区、北美、南美、欧洲和中东/非洲。在预测期内，北美占据骨化二醇补充品最大的市场占有率。

北美的老年人口正在增加。根据美国人口普查局的一项计划，美国约有 7,700 万人年龄在 65 岁及以上。加拿大的人口也在老化。人口老化导致的维生素 D 缺乏，加上许多成年人的维生素 D 缺乏，将显着增加北美地区对骨化二醇补充品的需求。儘管所有地区都面临着维生素 D 缺乏的问题，但北美，尤其是美国，寻求营养食品的人数不断增加，再加上健康领域的重大技术创新和进步，导致健康状况得到改善。设施的渗透，预计骨化二醇补充品市场的成长最快。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖关键和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业明智以及其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何塑造未来市场发展。
  • 可行的建议：利用洞察力做出策略决策，以在动态环境中发现新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业和市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开拓、竞争影响

调查范围

  • 2022年至2030年历史资料与预测
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争定位、策略和市场占有率分析
  • 细分市场和区域评估，包括收益成长和预测国家
  • 公司概况（尤其是关键发展等）

骨化二醇补充品市场细分与分析如下：

按类型

  • 即时释骨化二醇
  • 缓释骨化二醇

按用途

  • 维生素D缺乏症
  • 骨质疏鬆症
  • 次发性副甲状腺机能亢进
  • 其他的

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 其他的
  • 中东/非洲
  • 沙乌地阿拉伯
  • 以色列
  • 其他的
  • 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印尼
  • 泰国
  • 其他的

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章骨化二醇补充品市场：按类型

  • 介绍
  • 速释骨化二醇
  • 缓释性骨化二醇

第六章骨化二醇补充品市场：依应用分类

  • 介绍
  • 维生素D缺乏症
  • 骨质疏鬆症
  • 次发性副甲状腺机能亢进
  • 其他的

第七章骨化二醇补充品市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • Chemvon Biotechnolgy Co.
  • Haoyuan Chemexpress Co. Ltd.
  • BOC Science
  • Pharmaffiliates
  • DSM-Firmenich
  • Carbogen AMCIS
  • Chemicea
  • Midas Pharma
  • ApexBio Technolgy
  • OPKO Pharmaceuticals LLC
  • Nouveau Healthcare
  • Tocris Bioscience
简介目录
Product Code: KSI061614188

The Calcifediol Supplements Market is expected to grow at a CAGR of 9.21%, reaching a market size of US$2,189.3 million in 2030 from US$1,409.4 million in 2025.

Calcifediol is an active form of Vitamin D found in the bloodstream, also known as 25-hydroxyvitamin D3. It is produced by the liver by hydroxylation of Vitamin D3 that we get from sunlight or diet. It is used to measure the Vitamin D level in the body.

Calcifediol supplements are a more advanced and powerful type of vitamin D supplement. It has been clinically demonstrated to increase vitamin D levels three times quicker and more efficiently than other methods. Calcifediol monohydrate (25-Hydroxyvitamin D3) is a vitamin D3 analogue created by hydroxylation of vitamin D3 (cholecalciferol) using the enzyme cholecalciferol 25-hydroxylase.

The increasing Vitamin D deficiency worldwide and the aging population are driving the market growth for its supplements. Calcifediol is a better alternative than other forms of Vitamin D supplements as it is absorbed more quickly and increases Vitamin D levels by 3 times in the body, thus leading to an increase in its demand. Moreover, its usage in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis would help in increasing the calcifediol supplements market growth.

Calcifediol supplement market drivers

  • Rising Vitamin D deficiency would drive the market growth for calcifediol supplements

Globally, there is an increase in the number of people with Vitamin D deficiency. At the same time, the number of geriatric populations is on the rise worldwide. These factors are creating demand for Vitamin D supplements. Calcifediol is a superior alternative to other vitamin D supplements. It offers an effective solution for addressing vitamin D deficiency, providing a faster and more efficient method to raise vitamin D levels than traditional vitamin D3 supplements.

As per a study done by the National Center of Biotechnology Information, there are 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approximately 30-45% of people have vitamin D deficiency, making it around 1 billion people.

Calcifediol supplement market geographical outlook

  • North America would be the largest market shareholder for calcifediol supplements in the forecast period

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. North America would hold the largest market share for Calcifediol supplements in the forecast period.

North America is experiencing a demographic shift towards the older population. In the United States of America, there are around 77 million people aged above 65, according to the U.S. Census Bureau Project. In Canada, the aging population is increasing, too. Vitamin D deficiency in the aging population, coupled with deficiency in a great number of adults, would significantly increase the demand for calcifediol supplements in the North American region. Though all the regions are facing the issue of vitamin D deficiency, North America, particularly the United States of America, would have the highest growth in the calcifediol supplement market as there are increasing trends among people for dietary supplements and the prevalence of advanced healthcare infrastructure coupled with significant innovations and the advancement in the health sector.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The calcifediol supplement market is segmented and analyzed as given below:

By Type

  • Immediate-release calcifediol
  • Extended-release calcifediol

By Application

  • Vitamin D Deficiency
  • Osteoporosis
  • Secondary hyperparathyroidism
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. CALCIFEDIOL SUPPLEMENTS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Immediate-release calcifediol
  • 5.3. Extended-release calcifediol

6. CALCIFEDIOL SUPPLEMENTS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Vitamin D Deficiency
  • 6.3. Osteoporosis
  • 6.4. Secondary hyperparathyroidism
  • 6.5. Others

7. CALCIFEDIOL SUPPLEMENTS MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. UK
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. Israel
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Chemvon Biotechnolgy Co.
  • 9.2. Haoyuan Chemexpress Co. Ltd.
  • 9.3. BOC Science
  • 9.4. Pharmaffiliates
  • 9.5. DSM-Firmenich
  • 9.6. Carbogen AMCIS
  • 9.7. Chemicea
  • 9.8. Midas Pharma
  • 9.9. ApexBio Technolgy
  • 9.10. OPKO Pharmaceuticals LLC
  • 9.11. Nouveau Healthcare
  • 9.12. Tocris Bioscience